Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,010 | 331 | 152 | 138 | 47 |
| Cost of Goods | 488 | 167 | 53 | 45 | 13 |
| Gross Profit | 522 | 165 | 99 | 92 | 34 |
| Operating Expenses | 5,679 | 8,206 | 4,887 | 7,764 | 2,646 |
| Operating Income | -5,157 | -8,041 | -4,787 | -7,671 | -2,611 |
| Interest Expense | 1,669 | 1,236 | 1,011 | 1,223 | 672 |
| Other Income | 1,607 | -51 | 224 | 1,791 | -375 |
| Pre-tax Income | -5,219 | -9,328 | -5,575 | -7,104 | -3,658 |
| Income Tax | 7 | 34 | 3 | 3 | 12 |
| Net Income Continuous | -5,226 | -9,362 | -5,578 | -7,107 | -3,670 |
| Net Income | $-5,226 | $-9,362 | $-5,578 | $-7,107 | $-3,670 |
| EPS Basic Total Ops | -0.02 | -0.05 | -0.06 | -0.10 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.06 | -0.10 | N/A |
| EPS Diluted Total Ops | -0.02 | -0.05 | -0.06 | -0.10 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.06 | -0.10 | N/A |
| EBITDA(a) | $-2,905 | $-7,401 | $-3,911 | $-5,090 | $-2,589 |